Characterization of the immune response to canine parvovirus induced by vaccination with chimaeric plant viruses

Vaccine

Volumn 20, Issue 21-22, 2002, Pages 2727-2734

  Nicholas, Benjamin L ^a   Brennan, F R ^a   Martinez Torrecuadrada, J L ^a   Casal, J I ^a   Hamilton, W D ^a   Wakelin, D ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Immunity; Mucosal; Virus

Indexed keywords

CHIMERIC COW PEA MOSAIC VIRUS VACCINE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 4; INTERLEUKIN 5; KEYHOLE LIMPET HEMOCYANIN; MEMBRANE PROTEIN; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS VACCINE; IMMUNOGLOBULIN G; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; CANINE PARVOVIRUS; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG CONJUGATION; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VITRO STUDY; INTERMETHOD COMPARISON; INTESTINE; LYMPHOCYTE; MOSAIC VIRUS; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PARVOVIRUS; PLANT VIRUS; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; TRACHEOBRONCHIAL TOILET; VACCINATION; VIRUS INFECTION; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; MOLECULAR GENETICS; SERODIAGNOSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, INTRANASAL; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; COMOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MICE; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PARVOVIRUS, CANINE; PLANT VIRUSES; VACCINES, SYNTHETIC; VIRAL VACCINES; ANIMALS;

EID: 0037150476     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00200-1     Document Type: Article

References (34)

1. Live Salmonella vaccines as a route towards oral immunisation
2. Chimeras from a human rhinovirus 14-human immunodeficiency virus type 1 (HIV1) V3 loop seroprevalence library induce neutralizing responses against HIV-1
3. Poliovirus antigen chimeras
4. Non-replicating vaccinia vector efficiently expresses recombinant genes
5. Protein expression in vivo by injection of polynucleotides
6. DNA vaccines: Safety and efficacy issues
7. Recurrent thrombocytopenic purpura after repeated measles/mumps/rubella vaccination
8. Potential use of live viral and bacterial vectors for vaccines
9. Mucosal adjuvants
10. Adjuvants for human vaccines-current status, problems and future prospects
11. Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants
12. Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunisation
13. Multiple antigen constructs (MACs): Induction of sterile immunity against sporozoite stage of rodent malaria parasites, plasmodium berghei and plasmodium yoelii
14. The expression of hybrid HIV:ty virus-like particles in yeast
15. Expression of an animal virus antigenic on the surface of a plant virus particle
16. Development of cow pea moasic virus as a high-yielding system for the presentation of foreign peptides
17. Pseudomonas aeruginosa outer membrane protein F epitopes are highly immunogenic when expressed on a plant virus
18. Immunogenicity of peptides derived from a fibronectinbinding protein (FnBP) of S. aureus expressed on two different plant viruses
19. Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice
20. Characteristics and taxononmy of Parvoviridae
21. The emergence and evolution of canine parvovirus - An example of recent host-range mutation
22. The autonomously replicating parvoviruses of vertebrates
23. Pathogenesis of canine parvovirus enteritis: The importance of viremia
24. Recombinant vaccine for canine parvovirus in dogs
25. Peptide vaccine against canine parvovirus: Identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence
26. First peptide vaccine providing protection against viral infection in the target animal: Studies of canine parvovirus in dogs
27. Full protection in mink against enteritis virus with new generation canine parvovrius vaccines based on synthetic peptide or recombinant protein
28. Plant-derived vaccine protects target animals against a viral disease
29. Efficacy of oral vaccination against the murine intestinal parasite trichuris-muris is dependent upon host genetics
30. Fine-mapping of canine parvovirus B cell epitopes
31. A chimeric plant virus vaccine protects against bacterial infection
32. Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus
33. Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide
34. Mechanism of virus-induced Ig subclass shifts